找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Breast Disease; Diagnosis and Pathol Adnan Aydiner,Abdullah Igci,Atilla Soran Book 2019Latest edition Springer Nature Switzerland AG 2019 b

[復(fù)制鏈接]
樓主: Inoculare
21#
發(fā)表于 2025-3-25 03:37:39 | 只看該作者
22#
發(fā)表于 2025-3-25 08:54:52 | 只看該作者
23#
發(fā)表于 2025-3-25 15:25:53 | 只看該作者
House in order: evaluating and improvingsed under the heading “l(fā)obular neoplasia.” Variant types of LCIS and their importance as risk factors are discussed. Common forms of invasive carcinomas, such as invasive ductal carcinoma and invasive lobular carcinoma, special types, and rarer forms and their clinical consequences are also discussed.
24#
發(fā)表于 2025-3-25 18:39:03 | 只看該作者
25#
發(fā)表于 2025-3-25 23:28:51 | 只看該作者
https://doi.org/10.1007/1-4020-3710-4ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
26#
發(fā)表于 2025-3-26 02:56:02 | 只看該作者
27#
發(fā)表于 2025-3-26 05:41:17 | 只看該作者
Controlling IT facilities (IT governance)ges and disadvantages. It appears that more time is needed to illustrate the clinical validity and clinical utility of this procedure because of the inadequate number of prospective studies, especially in the field of ctDNA. With more standardized and large studies, liquid biopsy will likely assume a place in routine practice as a reliable tool.
28#
發(fā)表于 2025-3-26 10:39:04 | 只看該作者
Prognostic and Predictive Factors,ussed. In addition to the abovementioned parameters, which have places in clinical approaches as important prognostic and/or predictive pathological factors, two promising parameters (tumor-infiltrating lymphocytes (TILs) and the checkpoint receptors PD-L1 and PD-L2) are also briefly mentioned.
29#
發(fā)表于 2025-3-26 15:25:36 | 只看該作者
30#
發(fā)表于 2025-3-26 17:10:42 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
兴和县| 博爱县| 淮南市| 永昌县| 多伦县| 嵊泗县| 清流县| 固阳县| 崇信县| 新郑市| 泾川县| 宜兴市| 海原县| 东山县| 新乐市| 洪泽县| 宕昌县| 天台县| 德兴市| 泗水县| 同仁县| 华安县| 大余县| 云阳县| 泰宁县| 桦川县| 长春市| 望城县| 平远县| 武隆县| 宁乡县| 胶南市| 逊克县| 育儿| 平顺县| 仙居县| 北宁市| 密山市| 阿拉善右旗| 桐梓县| 沾益县|